CSS
MR

Cubist Systematic Strategies’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

Cubist Systematic Strategies’s Portfolio MR Stock Details MR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-7,266
Closed -$219K – 2187
2014
Q3 		$219K Buy
+7,266
New +$225K 0.01% 1319

Other funds holding MR

Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
GAM
Genesis Asset Managers Guernsey, Channel Islands, United Kingdom $3.53B AUM 1.54% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Cubist Systematic Strategies's MR Position: Q4 2014 in Review

Cubist Systematic Strategies sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q4 2014, closing a stake of 7,266 shares — an estimated $219K sold.

Cubist Systematic Strategies first reported a position in MR in Q3 2014 and held it in 1 quarter. The position peaked at $219K in Q3 2014. 137 funds tracked by Wall St. Rank hold MR as of Q4 2014.

  • Cubist Systematic Strategies reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q4 2014 after selling out during the quarter.
  • Cubist Systematic Strategies sold 7,266 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q4 2014, an estimated $219K.
  • Cubist Systematic Strategies first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q3 2014 and held it in 1 quarter.
  • Cubist Systematic Strategies's MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $219K in Q3 2014.
  • 137 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q4 2014.

Based on Cubist Systematic Strategies's 13F filing for Q4 2014, filed 17 Feb 2015.